Benlysta belimumab regulatory update

FDA accepted for filing and granted Priority Review to a BLA from Human Genome for Benlysta belimumab to treat systemic lupus erythematosus (SLE). The PDUFA date is Dec. 9. Partner GlaxoSmithKline sub...